VEGFA antibody (C-Term)

Catalog No. ABIN926640

The Rabbit Polyclonal anti-VEGFA antibody (ABIN926640) specifically detects VEGFA in WB. The antibody is reactive with Human samples.

Quick Overview for VEGFA antibody (C-Term) (ABIN926640)

Target: VEGFA (Vascular Endothelial Growth Factor A (VEGFA))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This VEGFA antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-VEGFA Antibody

Binding Specificity: C-Term

Purification: Purified

Immunogen: VEGFA antibody was raised in rabbit using the C terminal of VEGFA as the immunogen

Application Details

Application Notes: Optimal conditions should be determined by the investigator.

Comment:

VEGFA Blocking Peptide, (ABIN5616957), is also available for use as a blocking control in assays to test for specificity of this VEGFA antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Target Details for VEGFA

Target: VEGFA (Vascular Endothelial Growth Factor A (VEGFA))

Alternative Name: VEGFA

Background: This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Synonyms: Polyclonal VEGFA antibody, Anti-VEGFA antibody, vascular endothelial growth factor A antibody, MGC70609 antibody, MVCD1 antibody, VEGF antibody, VPF antibody.

Pathways: RTK Signaling, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling